Literature DB >> 8135530

Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51).

W Sattler1, M Maiorino, R Stocker.   

Abstract

The reaction of phospholipid hydroperoxide glutathione peroxidase (PHGPx) and Ebselen with phospholipid and cholesterylester hydroperoxides associated with HDLox and LDLox was investigated using specific HPLC assays for the hydroperoxides of phosphatidylcholine (PCOOH) and cholesteryllinolate (Ch18:2-OOH) and for cholesteryllinolate hydroxides (Ch18:2-OH). HDLox and LDLox were formed from the corresponding isolated native lipoproteins by controlled and limited oxidation initiated by aqueous peroxyl radicals. Incubation of HDLox or LDLox in the presence of PHGPx/GSH or Ebselen/GSH resulted in rapid degradation of both classes of lipid hydroperoxides, with equimolar amounts of Ch18:2-OH formed from Ch18:2-OOH. No pronounced differences were observed between PCOOH and Ch18:2-OOH in terms of substrate specificity, whereas HDLox-associated PCOOH and Ch18:2-OOH appeared to be slightly better substrates for PHGPx/GSH as compared to those in LDLox. Also, Ch18:2-OOH associated with HDLox but not LDLox were reduced by Ebselen or GSH alone. These in vitro findings indicate that the enzymatic PHGPx/GSH and the nonenzymatic Ebselen/GSH systems can efficiently reduce hydroperoxides of phospholipids and cholesterylesters associated with intact lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135530     DOI: 10.1006/abbi.1994.1105

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  17 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  Selenium supplementation for the primary prevention of cardiovascular disease.

Authors:  Karen Rees; Louise Hartley; Camilla Day; Aileen Clarke; Saverio Stranges
Journal:  Cochrane Database Syst Rev       Date:  2012

Review 3.  Biochemistry and pathology of radical-mediated protein oxidation.

Authors:  R T Dean; S Fu; R Stocker; M J Davies
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease.

Authors:  Min-Hyuk Yoo; Xinglong Gu; Xue-Ming Xu; Jin-Young Kim; Bradley A Carlson; Andrew D Patterson; Huaibin Cai; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

5.  Human blood cells support the reduction of low-density-lipoprotein-associated cholesteryl ester hydroperoxides by albumin-bound ebselen.

Authors:  J Christison; H Sies; R Stocker
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Functional characterization of cis- and trans-regulatory elements involved in expression of phospholipid hydroperoxide glutathione peroxidase.

Authors:  Christoph Ufer; Astrid Borchert; Hartmut Kuhn
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

7.  Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E.

Authors:  V Chajès; W Sattler; A Stranzl; G M Kostner
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

8.  Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ.

Authors:  J Christison; A Karjalainen; J Brauman; F Bygrave; R Stocker
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

9.  The Roles of Glutathione Peroxidases during Embryo Development.

Authors:  Christoph Ufer; Chi Chiu Wang
Journal:  Front Mol Neurosci       Date:  2011-07-28       Impact factor: 5.639

10.  Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2.

Authors:  Aniruddha Sengupta; Ulrike F Lichti; Bradley A Carlson; Christophe Cataisson; Andrew O Ryscavage; Carol Mikulec; Marcus Conrad; Susan M Fischer; Dolph L Hatfield; Stuart H Yuspa
Journal:  J Invest Dermatol       Date:  2013-01-30       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.